Teplizumab licensed for use by adults and older children in ‘breakthrough moment’
Teplizumab licensed for use by adults and older children in ‘breakthrough moment’
Copy link
Teplizumab can allow patients to live “normal lives” without the need for insulin injections
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start…
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an…
Teplizumab is approved for children aged eight and over
Product aims to disrupt the autoimmune attack against insulin-producing beta cells
